166 related articles for article (PubMed ID: 29629948)
41. Hemangioblastomas and neurogenic polyglobulia.
Gläsker S; Krüger MT; Klingler JH; Wlodarski M; Klompen J; Schatlo B; Hippchen B; Neumann HP; Van Velthoven V
Neurosurgery; 2013 Jun; 72(6):930-5; discussion 935. PubMed ID: 23407287
[TBL] [Abstract][Full Text] [Related]
42. [Comparison of paired box genes 8 and 2 expression in epithelium tissues and the related tumors].
Song Y; Huang X; Shen GH; Liu XY; Zhang X
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):424-428. PubMed ID: 28635231
[No Abstract] [Full Text] [Related]
43. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
[TBL] [Abstract][Full Text] [Related]
44. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
45. Loss of heterozygosity at 6q is frequent and concurrent with 3p loss in sporadic and familial capillary hemangioblastomas.
Lemeta S; Pylkkänen L; Sainio M; Niemelä M; Saarikoski S; Husgafvel-Pursiainen K; Böhling T
J Neuropathol Exp Neurol; 2004 Oct; 63(10):1072-9. PubMed ID: 15535134
[TBL] [Abstract][Full Text] [Related]
46. Epidemiology and clinical characteristics of hemangioblastomas in the elderly: An update.
Yoon JY; Gao A; Das S; Munoz DG
J Clin Neurosci; 2017 Sep; 43():264-266. PubMed ID: 28651893
[TBL] [Abstract][Full Text] [Related]
47. Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease.
Jagannathan J; Lonser RR; Smith R; DeVroom HL; Oldfield EH
J Neurosurg; 2008 Feb; 108(2):210-22. PubMed ID: 18240914
[TBL] [Abstract][Full Text] [Related]
48. Hypogonadotrophic hypogonadism due to intrasellar hemangioblastoma in von Hippel-Lindau syndrome.
Barton JC; Goncalves E; Santani A; Chandra-Sekar B; Morris EC; Carter BB; Stolle CA
Am J Med Genet A; 2009 Mar; 149A(3):549-51. PubMed ID: 19215058
[No Abstract] [Full Text] [Related]
49. Hemangioblastoma in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: a phenotypic overlap between VHL and HLRCC Syndromes.
Dow E; Winship IM
Fam Cancer; 2019 Jan; 18(1):91-95. PubMed ID: 29619618
[TBL] [Abstract][Full Text] [Related]
50. Teaching NeuroImages: CNS hemangioblastomas in von Hippel-Lindau disease with exon 3 deletion.
Chao CC; Tsai YS; Chen LW
Neurology; 2018 Aug; 91(6):e601-e602. PubMed ID: 30082448
[No Abstract] [Full Text] [Related]
51. Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management.
Catapano D; Muscarella LA; Guarnieri V; Zelante L; D'Angelo VA; D'Agruma L
Neurosurgery; 2005 Jun; 56(6):1215-21; discussion 1221. PubMed ID: 15918937
[TBL] [Abstract][Full Text] [Related]
52. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
[TBL] [Abstract][Full Text] [Related]
53. Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas.
Taïeb D; Barlier A; Yang C; Pertuit M; Tchoghandjian A; Rochette C; Zattara-Canoni H; Figarella-Branger D; Zhuang Z; Pacak K; Metellus P
J Neurooncol; 2016 Feb; 126(3):473-81. PubMed ID: 26514359
[TBL] [Abstract][Full Text] [Related]
54. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
[TBL] [Abstract][Full Text] [Related]
55. Developmental effects of von Hippel-Lindau gene deficiency.
Vortmeyer AO; Yuan Q; Lee YS; Zhuang Z; Oldfield EH
Ann Neurol; 2004 May; 55(5):721-8. PubMed ID: 15122713
[TBL] [Abstract][Full Text] [Related]
56. [Analysis of spinal cord hemangioblastoma in von Hippel-Lindau disease].
Nakashima H; Tokunaga K; Tamiya T; Matsumoto K; Ohmoto T; Furuta T
No Shinkei Geka; 1999 Jun; 27(6):533-40. PubMed ID: 10396736
[TBL] [Abstract][Full Text] [Related]
57. Gene symbol: VHL. Disease: von Hippel-Lindau syndrome. Accession #Hd0512.
Mavrogiannis LA; Sheridan EG; Burnell LD; Taylor GR
Hum Genet; 2006 Feb; 118(6):774-5. PubMed ID: 17297680
[No Abstract] [Full Text] [Related]
58. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma.
Hoang MP; Amirkhan RH
Am J Surg Pathol; 2003 Aug; 27(8):1152-6. PubMed ID: 12883249
[TBL] [Abstract][Full Text] [Related]
59. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
Wittström E; Nordling M; Andréasson S
Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas.
Miyagami M; Katayama Y; Nakamura S
Brain Tumor Pathol; 2000; 17(3):111-20. PubMed ID: 11310918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
